- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Home-based cardio-oncology rehabilitation using a telerehabilitation platform in hematological cancer survivors: a feasibility study2023 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society2020 | Faculty of Medicine in Hradec Králové
- Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)2020 | Faculty of Medicine in Hradec Králové
- Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018'2018 | Faculty of Medicine in Hradec Králové
- The Future Role of Cardio-oncologists2017 | Faculty of Medicine in Hradec Králové
- European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment2023 | Publication without faculty affiliation
- Cardiotoxicity - current guidelines2017 | Faculty of Medicine in Hradec Králové
- Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from theCardio-Oncology Study Groupof theHeart Failure Associationand theCardio-Oncology Council of the European Society of Cardiology2020 | Faculty of Medicine in Hradec Králové
- Summary of the 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines Prepared by the Czech Society of Cardiology2017 | Third Faculty of Medicine
- Summary of the 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines. Prepared by the Czech Society of Cardiology2017 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)2020 | Faculty of Medicine in Hradec Králové